NCT03803761 2023-09-25A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast CancerNational Cancer Institute (NCI)Phase 1/2 Withdrawn
NCT04334330 2022-05-02Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in ChinaSun Yat-sen UniversityPhase 2 Unknown34 enrolled